These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 19632929)
1. Polymorphisms in the enhancer region of the thymidylate synthase gene are associated with thymidylate synthase levels in normal tissues but not in malignant tissues of patients with colorectal cancer. Mauritz R; Giovannetti E; Beumer IJ; Smid K; Van Groeningen CJ; Pinedo HM; Peters GJ Clin Colorectal Cancer; 2009 Jul; 8(3):146-54. PubMed ID: 19632929 [TBL] [Abstract][Full Text] [Related]
2. Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers. Morganti M; Ciantelli M; Giglioni B; Putignano AL; Nobili S; Papi L; Landini I; Napoli C; Valanzano R; Cianchi F; Boddi V; Tonelli F; Cortesini C; Mazzei T; Genuardi M; Mini E Eur J Cancer; 2005 Sep; 41(14):2176-83. PubMed ID: 16182121 [TBL] [Abstract][Full Text] [Related]
3. Polymorphism in the thymidylate synthase promoter enhancer region is not an efficacious marker for tumor sensitivity to 5-fluorouracil-based oral adjuvant chemotherapy in colorectal cancer. Tsuji T; Hidaka S; Sawai T; Nakagoe T; Yano H; Haseba M; Komatsu H; Shindou H; Fukuoka H; Yoshinaga M; Shibasaki S; Nanashima A; Yamaguchi H; Yasutake T; Tagawa Y Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3700-4. PubMed ID: 14506161 [TBL] [Abstract][Full Text] [Related]
4. Associations between polymorphisms in the thymidylate synthase gene, the expression of thymidylate synthase mRNA and the microsatellite instability phenotype of colorectal cancer. Merkelbach-Bruse S; Hans V; Mathiak M; Sanguedolce R; Alessandro R; Rüschoff J; Büttner R; Houshdaran F; Gullotti L Oncol Rep; 2004 Apr; 11(4):839-43. PubMed ID: 15010882 [TBL] [Abstract][Full Text] [Related]
5. Polymorphic tandem repeat sequences of the thymidylate synthase gene correlates with cellular-based sensitivity to fluoropyrimidine antitumor agents. Yawata A; Kim SR; Miyajima A; Kubo T; Ishida S; Saito Y; Nakajima Y; Katori N; Matsumoto Y; Fukuoka M; Ohno Y; Ozawa S; Sawada J Cancer Chemother Pharmacol; 2005 Nov; 56(5):465-72. PubMed ID: 15918040 [TBL] [Abstract][Full Text] [Related]
6. Thymidylate synthase gene polymorphism predicts toxicity in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy. Lecomte T; Ferraz JM; Zinzindohoué F; Loriot MA; Tregouet DA; Landi B; Berger A; Cugnenc PH; Jian R; Beaune P; Laurent-Puig P Clin Cancer Res; 2004 Sep; 10(17):5880-8. PubMed ID: 15355920 [TBL] [Abstract][Full Text] [Related]
7. Association of thymidylate synthase enhancer region polymorphisms with thymidylate synthase activity in vivo. de Bock CE; Garg MB; Scott N; Sakoff JA; Scorgie FE; Ackland SP; Lincz LF Pharmacogenomics J; 2011 Aug; 11(4):307-14. PubMed ID: 20531375 [TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of thymidylate synthase at the protein, mRNA, and DNA levels as prognostic markers in colorectal adenocarcinoma. Ren DN; Kim IY; Koh SB; Chang SJ; Eom M; Yi SY; Seong SH; Kim MD; Bronner MP; Cho MY J Surg Oncol; 2009 Dec; 100(7):546-52. PubMed ID: 19722231 [TBL] [Abstract][Full Text] [Related]
10. Thymidylate synthase gene promoter polymorphisms are associated with TSmRNA expressions but not with microsatellite instability in colorectal cancer. Calascibetta A; Cabibi D; Martorana A; Sanguedolce G; Rausa L; Feo S; Dardanoni G; Sanguedolce R Anticancer Res; 2004; 24(6):3875-80. PubMed ID: 15736425 [TBL] [Abstract][Full Text] [Related]
11. Association of thymidylate synthase gene polymorphism with its mRNA and protein expression and with prognosis in gastric cancer. Ishida Y; Kawakami K; Tanaka Y; Kanehira E; Omura K; Watanabe G Anticancer Res; 2002; 22(5):2805-9. PubMed ID: 12530000 [TBL] [Abstract][Full Text] [Related]
12. Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression. Kawakami K; Salonga D; Park JM; Danenberg KD; Uetake H; Brabender J; Omura K; Watanabe G; Danenberg PV Clin Cancer Res; 2001 Dec; 7(12):4096-101. PubMed ID: 11751507 [TBL] [Abstract][Full Text] [Related]
13. Thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer and normal mucosa in patients. Amatori F; Di Paolo A; Del Tacca M; Fontanini G; Vannozzi F; Boldrini L; Bocci G; Lastella M; Danesi R Pharmacogenet Genomics; 2006 Nov; 16(11):809-16. PubMed ID: 17047489 [TBL] [Abstract][Full Text] [Related]
14. Polymorphism in the thymidylate synthase promoter enhancer region modifies the risk and survival of colorectal cancer. Chen J; Hunter DJ; Stampfer MJ; Kyte C; Chan W; Wetmur JG; Mosig R; Selhub J; Ma J Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):958-62. PubMed ID: 14578129 [TBL] [Abstract][Full Text] [Related]
15. A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil. Iacopetta B; Grieu F; Joseph D; Elsaleh H Br J Cancer; 2001 Sep; 85(6):827-30. PubMed ID: 11556832 [TBL] [Abstract][Full Text] [Related]
16. Heterozygote deficiency in thymidylate synthase enhancer region polymorphism genotype distribution in Hungarian colorectal cancer patients. Adleff V; Hitre E; Köves I; Orosz Z; Hajnal A; Kralovánszky J Int J Cancer; 2004 Mar; 108(6):852-6. PubMed ID: 14712487 [TBL] [Abstract][Full Text] [Related]
17. Polymorphisms of folate pathway enzymes (methylenetetrahydrofolate reductase and thymidylate synthase) and their relationship with thymidylate synthase expression in human astrocytic tumors. da Costa DM; de Lima GP; Faria MH; Rabenhorst SH DNA Cell Biol; 2012 Jan; 31(1):57-66. PubMed ID: 21848426 [TBL] [Abstract][Full Text] [Related]
18. Simultaneous detection of variable number tandem repeats, single nucleotide polymorphisms, and allelic imbalance in the thymidylate synthase gene enhancer region using denaturing high-performance liquid chromatography. Ezzeldin H; Hoffmayer C; Soong R; Johnson MR; Lee A; Heslin M; Diasio R Anal Biochem; 2004 Nov; 334(2):276-83. PubMed ID: 15494134 [TBL] [Abstract][Full Text] [Related]
19. Thymidylate synthase gene polymorphism affects the response to preoperative 5-fluorouracil chemoradiation therapy in patients with rectal cancer. Hur H; Kang J; Kim NK; Min BS; Lee KY; Shin SJ; Keum KC; Choi J; Kim H; Choi SH; Lee MY Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):669-76. PubMed ID: 20932673 [TBL] [Abstract][Full Text] [Related]
20. Polymorphism in the thymidylate synthase promoter enhancer region in colorectal cancer. Marsh S; McKay JA; Cassidy J; McLeod HL Int J Oncol; 2001 Aug; 19(2):383-6. PubMed ID: 11445856 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]